Lawson Macartney - Nov 8, 2024 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
Director
Signature
/s/ Michael Morneau as Attorney-in-Fact
Stock symbol
VKTX
Transactions as of
Nov 8, 2024
Transactions value $
-$125,733
Form type
4
Date filed
11/8/2024, 06:22 PM
Previous filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $11.6K +2K +4.17% $5.80 50K Nov 8, 2024 Direct
transaction VKTX Common Stock, par value $0.00001 per share Sale -$137K -2K -4% $68.67 48K Nov 8, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VKTX Stock Option (Right to Buy) Options Exercise $0 -2K -9.09% $0.00 20K Nov 8, 2024 Common Stock 2K $5.80 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.